You are here: Industry Insights > Pfizer

News List

Pfizer’s JAK inhibitor Xeljanz shows benefit in COVID-19 pneumonia pharmatimes
June 21, 2021
Pfizer’s JAK inhibitor Xeljanz reduced the risk of severe outcomes in hospitalised adult patients with COVID-19 pneumonia who were not on ventilation, according to new study data.
China, Other Asian Countries Vaccinate Against Covid-19 Faster Than Ever firstwordpharma
June 21, 2021
COVID-19 vaccine rollouts have accelerated in many Asia-Pacific countries in recent weeks, overtaking the pace of doses being administered in Western nations, The Wall Street Journal reported on Sunday.
Israel Says it Sent ‘Completely Normal’ Vaccines to Palestinians firstwordpharma
June 21, 2021
Israel's Health Ministry said that the first batch of Pfizer's vaccine Israel sent to the Palestinian Authority as part of a larger swap deal was "completely normal" and identical to the vaccines being given to Israeli citizens, Bloomberg reported.
Pfizer, Moderna Vaccines Do No Harm to Male Fertility: Study drugs
June 18, 2021
The Pfizer and Moderna COVID vaccines pose no threat to male fertility, a finding experts hope will prompt more men to get vaccinated.
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia firstwordpharma
June 17, 2021
Pfizer Inc. (NYSE: PFE) and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive findings from the STOP-COVID study (NCT04469114) evaluating
Comirnaty® COVID-19 vaccine protects against multiple viral variants europeanpharmaceuticalreview
June 16, 2021
Laboratory study shows the blood sera of people vaccinated against COVID-19 with Comirnaty® can neutralise at least six viral variants including three variants of concern.
DoctorOnCall, Pfizer and UOB Malaysia form Malaysia's first tripartite collaboration to improve children's access to pneumococcal vaccine prnasia
June 16, 2021
DoctorOnCall, Pfizer and UOB Malaysia today jointly launched "ASK4VACCINE", a financing programme that aims to improve children's access to pneumococcal vaccine in Malaysia.
Pfizer ready to make COVID vaccines for new variants, CEO says firstwordpharma
June 15, 2021
Pfizer's CEO Albert Bourla is expressing confidence about the efficacy of his company's COVID-19 vaccine against the Delta variant, which was first detected in India, as reported by MSN.
Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation contractpharma
June 11, 2021
Pfizer Inc. and BioNTech SE plan to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in 1H22.
FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older firstwordpharma
June 11, 2021
Pfizer Inc. (NYSE:PFE) announced today that FDA has approved Prevnar 20™ (Pneumococcal 20-valent Conjugate Vaccine) for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae serotypes in the vaccine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page